Philadelphia, PA - Wyeth-Ayerst Pharmaceuticals have issued a letter alerting healthcare professionals to two dangers of Cordarone IV® (amiodarone HCL) use in pediatric patients, and detailing related ...
KING OF PRUSSIA, Pa., Jan. 5 /PRNewswire/ -- Prism Pharmaceuticals announced today that the U.S. Food & Drug Administration (FDA) has approved the new drug application (NDA) for NEXTERONE(R) ...
Inadvertent administration may result in serious adverse events. Mylan announced the voluntary recall to the hospital/clinic level of 4 lots of Amiodarone HCl Injection, USP 450mg/9mL and Tranexamic ...
Boston, MA - Significantly more cardiac arrest patients with shock-resistant ventricular fibrillation (VF) survived to hospital admission when given amiodarone instead of lidocaine, according to a ...
HealthDay News — In a report published online July 16 in the Journal of Clinical Pharmacy and Therapeutics, a case of survival after acute liver failure secondary to amiodarone administration is ...
Multiple placebo-controlled trials have demonstrated that intravenous vernakalant, a novel antiarrhythmic agent, effectively converts recent-onset atrial fibrillation in ∼50% of patients within 90 min ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results